MK-801 POTENTIATES DOPAMINERGIC-D1 BUT REDUCES D2 RESPONSES IN THE 6-HYDROXYDOPAMINE MODEL OF PARKINSONS-DISEASE

被引：104
|
作者：
MORELLI, M
DICHIARA, G
机构：
[1] Institute of Experimental Pharmacology and Toxicology, University of Cagliari, Cagliari
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 1990年 / 182卷 / 03期
关键词：
D O I：
10.1016/0014-2999(90)90066-F
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：611 / 612
页数：2
相关论文
共 37 条
  • [31] Vitamin D Treatment Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in an Animal Model of Parkinson's Disease, Shifting M1 to M2 Microglia Responses
    Calvello, Rosa
    Cianciulli, Antonia
    Nicolardi, Giuseppe
    De Nuccio, Francesco
    Giannotti, Laura
    Salvatore, Rosaria
    Porro, Chiara
    Trotta, Teresa
    Panaro, Maria Antonietta
    Lofrumento, Dario Domenico
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2017, 12 (02) : 327 - 339
  • [32] Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW 373U86 and SNC 80:: 3.: Facilitation of D1 and D2 responses in unilaterally 6-hydroxydopamine-lesioned rats
    Pinna, A
    Di Chiara, G
    BEHAVIOURAL PHARMACOLOGY, 1998, 9 (01): : 15 - 21
  • [33] The high-affinity D2/D3 agonist D512 protects PC12 cells from 6-OHDA-induced apoptotic cell death and rescues dopaminergic neurons in the MPTP mouse model of Parkinson's disease
    Shah, Mrudang
    Rajagopalan, Subramanian
    Xu, Liping
    Voshavar, Chandrashekhar
    Shurubor, Yevgeniya
    Beal, Flint
    Andersen, Julie K.
    Dutta, Aloke K.
    JOURNAL OF NEUROCHEMISTRY, 2014, 131 (01) : 74 - 85
  • [34] The vesamicol receptor ligand (+)-meta-[I-125]iodobenzyltrozamicol {(+)-[I-125]-MIBT} reveals blunting of the striatal cholinergic response to dopamine D2 receptor blockade in the 6-hydroxydopamine (6-OHDA)-lesioned rat: Possible implications for Parkinson's disease
    Efange, SMN
    Langason, RB
    Khare, AB
    Low, WC
    LIFE SCIENCES, 1996, 58 (16) : 1367 - 1374
  • [35] Blockade D1-like and D2-like dopamine receptors within nucleus accumbens attenuate hyperalgesia responses in a 6-OHDA induced parkinson's disease rat model
    Li, L.
    Mao, C. J.
    Zhang, X. Q.
    Wang, F.
    Liu, C. F.
    MOVEMENT DISORDERS, 2018, 33 : S745 - S745
  • [36] ANTINOCICEPTION INDUCED BY 3-((PLUS-OR-MINUS)-2-CARBOXYPIPERAZIN-4-YL)-PROPYL-1-PHOSPHONIC ACID (CPP), AN N-METHYL-D-ASPARTATE (NMDA) COMPETITIVE ANTAGONIST, PLUS 6,7-DINITROQUINOXALINE-2,3-DIONE (DNQX), A NON-NMDA ANTAGONIST, DIFFERS FROM THAT INDUCED BY MK-801 PLUS DNQX
    GOETTL, VM
    LARSON, AA
    BRAIN RESEARCH, 1994, 642 (1-2) : 334 - 338
  • [37] (6aR)-11-Amino-N-propyl-noraporphine, a new dopamine D2 and serotonin 5-HT1A dual agonist, elicits potent antiparkinsonian action and attenuates levodopa-induced dyskinesia in a 6-OHDA-lesioned rat model of Parkinson's disease
    Zhao, Rui
    Lu, Weijian
    Fang, Xing
    Guo, Lin
    Yang, Zhi
    Ye, Na
    Zhao, Jiahao
    Liu, Zhili
    Jia, Jia
    Zheng, Longtai
    Zhao, Bin
    Zhang, Ao
    Zhen, Xuechu
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2014, 124 : 204 - 210
1234